News - 2005 / 2006


Winter 2006 News

The biochemical underpinnings of T cell anergy in vivo.

Biochemical studies of T cell anergy, a correlate of some tolerance states in vivo, has been hampered because anergic cells are growth-arrested and could not be efficiently transduced with existing retroviral systems.  The Gajewski lab developed a new system of adenoviral transduction using T cells that transgenically express the coxsackie and adenovirus receptor (CAR) to genetically manipulate anergic T cells. Experiments demonstrated for the first time that defective Ras activity was the cause of anergy and identified diacylglycerolkinases as negative regulators of Ras in anergic cells (Nature Immunol 2006, 7, 1166).  These findings open the way to the development of pharmacological agents that prevent anergy to augment T cell responses to cancer vaccines. 



Novel mechanisms underlying the generation of tumor specific antigen identified in the Schreiber lab


Natural, tumor specific antigens are highly desirable targets for immune therapy of cancer.  A tumor associated mutation of the chaperone Cosmc, which regulates the function of a glycosyltransferase, resulted in the creation of a tumor specific glycopeptidic epitope. These neo epitopes could be efficiently targeted by monoclonal antibodies, raising the prospect of monoclonal antibody therapy (Schietinger et al., Science 2006, 314, 304).

Fall 2006 News

The Fritz and Ursula Melschers Prize to Dr. Jochen Mattner

Jochen Mattner, Research Assistant Professor in the Bendelac Lab, was awarded the Fritz and Ursula Melchers Prize this year at the Joint meeting of the European Societies for Immunology in Paris, France, for his work on the biology of NKT cells.  Dr Mattner demonstrated that NKT cells exert innate like anti-microbial functions by recognizing alpha-glycuronylceramides expressed in the cell wall of some Gram-negative LPS-negative bacteria.  His research also characterized another pathway of NKT cell activation triggered by the induction of a self glycosphingolipid, iGb3, during infections with LPS-expressing bacteria.   The work was published in Nature, March 2005, (Volume 434, pages 525-529).

Summer 2006 News

The Fu laboratory: on the role of tertiary lymphoid stuctures in autoimmunity.

Tertiary lymphoid structures are ectopic lymph node-like structures appearing in organs undergoing various chronic forms of inflammation and autoimmunity.   The Fu laboratory has now demonstrated the role of LIGHT and lymphotoxin beta receptor in the organogenesis of these structures.  In the NOD mouse model of type I diabetes, the tertiary lymphoid structures appear to be sufficient for the development of autoimmunity.  This study, done in collaboration with Dr Sasha Chervonsky another COI faculty at the University of Chicago and published in Immunity September, 2006 (Volume 25, page 499-509) suggests new approaches to the treatment of autoimmunity based on interference with the LIGHT/Lymphotoxin beta receptor pathway.

Spring 2006 News

Barbara Kee awarded the 2006 AAI Cynthia Chambers Memorial-EBioscience Junior Faculty Award

Dr. Kee's research investigates the role of transcription factors of the E2 family in lymphocyte development and carcinogenesis. The AAI award honors the memory of Dr. Cynthia Chambers and was established to advance the career of junior scientists, specifically in the area of cancer biology. Dr. Kee will present her research at the next Annual Meeting of the American Association of Immunolgists, held May 12-16, 2006 in Boston, MA.

 



Katie Sawai, a COI graduate student in the Aifantis lab awarded a $1,000 scholarship to attend this year's "T cell signaling and activation" Keystone meeting in Steamboat Springs, Colorado.

Katie Sawai presented a poster entitled "A unique role for cyclin D3 in early B cell development".

 

Winter 2005 News

The Aifantis laboratory reveals that Hedgehog signaling regulates lymphocyte progenitor development in the thymus.

In a paper now in press in Nature Immunology entitled "Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus" and co-first authored by postdoc Abdel El Andaloussi and MSTP student Stephanie Graves, the lab used T cell specific conditional deletions of the Hedgehog receptor Smoothened to demonstrate that the Hedgehog signaling pathway is one of the important regulators of lymphocyte progenitor development in the thymus.

 

Fall 2005 News

A COI post-doctoral fellow, Luqiu Chen, is awarded an American Heart Association fellowship.

 
A post-doctoral fellow in the Alegre lab, Luqiu Chen, was awarded an AHA fellowship to continue a collaborative project between the Alegre and Chong laboratories. Luqiu Chen studies the role of TLR signaling during immune responses to transplanted organs.

 


COI graduate student Ruth Taniguchi receives the Best Poster Award at the International Workshop on NK cells and Innate Immunity in Hawaii November 4-8, 2005.

Ruth Taniguchi's thesis research in the Kumar laboratory focuses on the function of the surface receptor 2B4 expressed at the surface of mouse and human NK cells. Ruth is in her 3rd year of graduate studies in the Committee on Immunology at the University of Chicago.

 



Choosing between death and proliferation. The role of a Serine 194 in FADD, the death domain containing adaptor and its regulator, the Casein Kinase Iα uncovered in Marcus Peter’s laboratory.

While FADD is a well-established regulator of apoptosis mediated by Death Receptors such as CD95 (APO-1/Fas), a number of studies have indicated interferences with cell cycle and cell proliferation. The Peter lab has now uncovered the role of Caseine Kinase Iα as regulator of FADD through phosphorylation of Serine 194. FADD and CKIα colocalize on the spindle poles in cell metaphase, representing a crucial event during mitosis. This pathway also regulates the ability of Taxol to arrest cells in mitosis, raising the possibility that compounds that activate CKIα to increase FADD phosphorylation may act as chemosensitizers for cancer treatment (E. Alapatt et al., Molecular Cell 2005, 19, 321-332)

 



Four new COI Faculty join the University of Chicago: Drs. Erin Adams, David Boone, Sasha Chervonsky and Tanya Golovkina

Erin Adams, PhD, joins the Department of Biochemistry and Molecular Biology as an Assistant Professor. Erin trained at Stanford with Peter Parham (graduate studies) and Chris Garcia (postdoctoral research). A biochemist and crystallographer, she elucidated the first structure of a TCRγδ bound to its ligand.


David Boone, PhD, joins the Department of Medicine, Center for Inflammatory Bowel Diseases as an Assistant Professor. David trained with Averil Ma at the University of Chicago then at UC San Francisco and made major contributions to the understanding of inflammation and NF?ß regulation in the intestinal mucosa through novel biochemical mechanisms of ubiquitination.


Sasha Chervonsky, PhD, joins the Department of Pathology as an Associate Professor with tenure. Sasha’s laboratory studies the development of Peyer’s patches in the small bowel, the role of endothelial cells in antigen presentation in autoimmune Type I Diabetes and the role of MHC in central tolerance.



Tanya Golovkina, PhD, joins the Department of Microbiology as an Associate Professor with tenure. Tanya’s laboratory studies models of retroviral induction of mammary tumors in mouse and has discovered entirely new ways in which retroviruses manipulate the immune system.

 



Bana Jabri promoted to the rank of Associate Professor with Tenure

Bana Jabri MD, PhD, who joined the Faculty at the University of Chicago in 2002 as an Assistant Professor in the Department of Pathology with secondary appointments in Pediatrics and Medicine, was promoted to the rank of Associate Professor with tenure. Bana’s laboratory is in the Center for Inflammatory Bowel Diseases and studies Celiac Disease, a human disease resulting from an aberrant immune response in the small bowel to the gluten found in wheat. Her work has elucidated the mechanism leading to the destruction of intestinal epithelial cells by intraepithelial lymphocytes in patients with celiac disease. More generally, her research demonstrates new elements of a cross talk between the tissue and the immune system that regulates cytolytic responses in the mucosal environment.


Summer 2005 News

Two University of Chicago undergraduate students in COI labs receive HHMI award

Shayla Hesse and Dustin Guzior, two University of Chicago undergraduate students, received a Best Presentation Award from the Howard Hughes Medical Institute Summer Research Program for their studies in COI laboratories.


Shayla Hesse has been working in the Alegre lab and presented her unexpected observation that reduced T cell NF-kB promotes the formation of anti-nuclear antibodies in a mouse model of lupus. Dustin Guzior was working in the Kumar lab, establishing a role for 2B4 in NK cell self-tolerance.



 

 

Committee On Immunology

News Archive


Cancer Biology


CCB

Immunology


COI

Microbiology


COM

Molecular Metabolism
and Nutrition


CMMN

Molecular Pathogenesis and
Molecular Medicine


MPMM